Braskem (NYSE:BAK) Stock Bumped Down to “Sell” by Wall Street Zen

Wall Street Zen downgraded shares of Braskem (NYSE:BAK – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning,Wall Street Zen reports.

Several other equities analysts have also recently weighed in on the company. UBS Group reduced their price target on Braskem from $1.50 to $0.75 and set a “sell” rating for the company in a research report on Thursday. Weiss Ratings restated a “sell (e+)” rating on shares of Braskem in a report on Thursday, October 15th. Finally, HSBC downgraded shares of Braskem from a “buy” rating to a “hold” rating and dropped their target price for the stock from $6.50 to $1.50 in a research note on Monday, September 28th. Three equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Strong Sell” and an average price target of $2.41.

View Our Latest Stock Analysis on BAK

Braskem Price Performance

BAK opened at $0.74 on Friday. Braskem has a fifty-two week low of $0.73 and a fifty-two week high of $5.39. The firm has a market capitalization of $296.32 million, a price-to-earnings ratio of -0.25 and a beta of 1.68. The company’s 50 day moving average price is $1.45 and its two-hundred day moving average price is $2.84.

Braskem (NYSE:BAK – Get Free Report) last released its earnings results on Friday, November 13th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.54). Braskem had a negative return on equity of 41.73% and a negative net margin of 8.40%. The business had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.64 billion. As a group, equities research analysts predict that Braskem will post -0.33 EPS for the current year.

Institutional Trading of Braskem

A number of hedge funds and other institutional investors have recently made changes to their positions in BAK. Cetera Investment Advisers acquired a new position in Braskem in the first quarter valued at approximately $51,000. Bank of America Corp DE grew its position in Braskem by 178,471.4% in the first quarter. Bank of America Corp DE now owns 50,000 shares of the company’s stock worth $183,000 after acquiring an additional 49,972 shares during the period. Citadel Advisors LLC acquired a new stake in Braskem during the second quarter worth $89,000. Goldman Sachs Group Inc. increased its stake in Braskem by 1,729.5% during the third quarter. Goldman Sachs Group Inc. now owns 931,022 shares of the company’s stock worth $1,350,000 after acquiring an additional 880,133 shares during the last quarter. Finally, Private Advisor Group LLC acquired a new stake in Braskem during the third quarter worth $156,000.

About Braskem

(Get Free Report)

Braskem is a Brazilian petrochemical company that produces thermoplastic resins and basic petrochemicals used in packaging, construction, automotive manufacturing, consumer goods and other industries. Its products include polyethylene, polypropylene and polyvinyl chloride, as well as chemical building blocks such as ethylene and propylene. The company also makes bio-based plastics, including polyethylene produced from sugarcane-derived ethanol and marketed under its I’m green brand. These materials are designed to serve applications similar to those of conventional plastics.

Read More

Analyst Recommendations for Braskem (NYSE:BAK)

Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.